GJB3 and cancer: As a potential drug target for the failure of chemotherapy, Connexin 32 internalization by USP14 inhibition modulates cisplatin resistance in ovarian cancer cells [22]; however, little attention has been paid to the role of GJB3 in cancer, especially from a pan-cancer perspective.